Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution

Mona M. Wang, Yuanhan Li, Candice E. H. Ho, Willie S. S. Yu, Sarah E. Coupland, Gayoung Park, Anita S. Y. Chan, Carlos R. Figueiredo · 2026

Read Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution by Mona M. Wang, Yuanhan Li, Candice E. H. Ho, Willie S. S. Yu, Sarah E. Coupland, Gayoung Park, Anita S. Y. Chan, Carlos R. Figueiredo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13470363.txt.

Description

Mona M Wang and seven co-authors build a mouse model of a hard to treat form of melanoma, in this 2026 study. These tumors lack a gene called BAP1, which makes them aggressive and good at shutting down the immune system. No lab model with a working immune system existed for them, which blocked tests of new immune based treatments.

The team used gene editing to knock out the gene in mouse pigment cells. The resulting tumors grew fast, showed the cell shape of aggressive human cases, and carried the same immune suppressing traits. A cell by cell comparison of gene activity showed strong overlap with high risk human eye melanomas, including a shared shift in fat chemistry. The model now gives researchers a test bed for combination therapies.

Catalog record

CREATORMona M. Wang, Yuanhan Li, Candice E. H. Ho, Willie S. S. Yu, Sarah E. Coupland, Gayoung Park, Anita S. Y. Chan, Carlos R. Figueiredo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE89 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13470363

Browse the full library · About the Tower of Babel